COPD and Schizophrenia.

IF 2.3 4区 医学 Q2 RESPIRATORY SYSTEM
Sophie Ratcliffe, David M G Halpin
{"title":"COPD and Schizophrenia.","authors":"Sophie Ratcliffe, David M G Halpin","doi":"10.15326/jcopdf.2025.0631","DOIUrl":null,"url":null,"abstract":"<p><p>The prevalence of COPD is higher in people with schizophrenia than in the general population even after adjusting for smoking, but schizophrenia has not generally been considered in discussions of COPD multimorbidity. People with schizophrenia die prematurely and COPD is an important but neglected cause of this mortality. People with schizophrenia have a higher prevalence of ever smoking tobacco than the general population. The link between COPD and schizophrenia may be partially explained by higher rates of smoking, but may also be syndemic, with shared genetic, socioeconomic and environmental risk factors and common pathophysiological mechanisms. People with a mental illness tend to receive medical care intermittently, there is often a lack of continuity of care and primary and preventive services are infrequently used. Physical symptoms may be viewed as \"psychosomatic\" leading to under-diagnosis. People with schizophrenia are less likely to receive adequate general medical care, including investigation and treatment, in line with guidelines. Antipsychotic drugs are associated with adverse effects that may be problematic in people with COPD. The management and outcomes for people with schizophrenia and COPD could be improved by reducing stigma, developing Integrated services, undertaking physical health checks that include asking about respiratory symptoms and arranging spirometry when indicated, care coordination that includes addressing physical health issues, vaccination, support with smoking cessation, exercise and pulmonary rehabilitation.</p>","PeriodicalId":51340,"journal":{"name":"Chronic Obstructive Pulmonary Diseases-Journal of the Copd Foundation","volume":" ","pages":""},"PeriodicalIF":2.3000,"publicationDate":"2025-06-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Chronic Obstructive Pulmonary Diseases-Journal of the Copd Foundation","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.15326/jcopdf.2025.0631","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"RESPIRATORY SYSTEM","Score":null,"Total":0}
引用次数: 0

Abstract

The prevalence of COPD is higher in people with schizophrenia than in the general population even after adjusting for smoking, but schizophrenia has not generally been considered in discussions of COPD multimorbidity. People with schizophrenia die prematurely and COPD is an important but neglected cause of this mortality. People with schizophrenia have a higher prevalence of ever smoking tobacco than the general population. The link between COPD and schizophrenia may be partially explained by higher rates of smoking, but may also be syndemic, with shared genetic, socioeconomic and environmental risk factors and common pathophysiological mechanisms. People with a mental illness tend to receive medical care intermittently, there is often a lack of continuity of care and primary and preventive services are infrequently used. Physical symptoms may be viewed as "psychosomatic" leading to under-diagnosis. People with schizophrenia are less likely to receive adequate general medical care, including investigation and treatment, in line with guidelines. Antipsychotic drugs are associated with adverse effects that may be problematic in people with COPD. The management and outcomes for people with schizophrenia and COPD could be improved by reducing stigma, developing Integrated services, undertaking physical health checks that include asking about respiratory symptoms and arranging spirometry when indicated, care coordination that includes addressing physical health issues, vaccination, support with smoking cessation, exercise and pulmonary rehabilitation.

慢性阻塞性肺病和精神分裂症。
即使在吸烟因素调整后,精神分裂症患者的COPD患病率也高于普通人群,但在COPD多病的讨论中,精神分裂症通常未被考虑在内。精神分裂症患者过早死亡,慢性阻塞性肺病是导致这种死亡的一个重要但被忽视的原因。精神分裂症患者吸烟的比例高于一般人群。慢性阻塞性肺病和精神分裂症之间的联系部分可以用较高的吸烟率来解释,但也可能是综合征,具有共同的遗传、社会经济和环境风险因素以及共同的病理生理机制。患有精神疾病的人往往间歇性地接受医疗护理,往往缺乏连续性的护理,初级和预防服务很少得到使用。身体症状可能被视为“心身”,导致诊断不足。精神分裂症患者不太可能得到适当的一般医疗护理,包括根据指南进行的调查和治疗。抗精神病药物与COPD患者可能出现的不良反应有关。可通过以下方式改善精神分裂症和慢性阻塞性肺病患者的管理和结果:减少耻辱感、发展综合服务、开展身体健康检查(包括询问呼吸道症状并在需要时安排肺活量测定)、护理协调(包括解决身体健康问题)、接种疫苗、支持戒烟、锻炼和肺部康复。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
3.70
自引率
8.30%
发文量
45
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信